From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001
- PMID: 11596606
Item in Clipboard
From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001
JAMA.
.
No abstract available
Similar articles
-
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.MMWR Morb Mortal Wkly Rep. 2001 Aug 31;50(34):733-5. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11787580
-
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):998-9. MMWR Morb Mortal Wkly Rep. 2002. PMID: 12455909
-
From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.JAMA. 2002 Dec 18;288(23):2967. doi: 10.1001/jama.288.23.2967-jwr1218-6-1. JAMA. 2002. PMID: 12492097 No abstract available.
-
Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?Am J Respir Crit Care Med. 2003 Mar 15;167(6):809-10. doi: 10.1164/rccm.2301002. Am J Respir Crit Care Med. 2003. PMID: 12623855 Review. No abstract available.
-
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.Expert Opin Drug Saf. 2004 May;3(3):187-98. doi: 10.1517/eods.3.3.187.31073. Expert Opin Drug Saf. 2004. PMID: 15155147 Review.
Cited by
-
Adverse events associated with treatment of latent tuberculosis in the general population.CMAJ. 2011 Feb 22;183(3):E173-9. doi: 10.1503/cmaj.091824. Epub 2011 Jan 10. CMAJ. 2011. PMID: 21220436 Free PMC article.
-
Updates on the risk factors for latent tuberculosis reactivation and their managements.Emerg Microbes Infect. 2016 Feb 3;5(2):e10. doi: 10.1038/emi.2016.10. Emerg Microbes Infect. 2016. PMID: 26839146 Free PMC article. Review.
-
The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China.Front Pharmacol. 2021 May 10;12:657805. doi: 10.3389/fphar.2021.657805. eCollection 2021. Front Pharmacol. 2021. PMID: 34040524 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
